Navigation Links
China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31, 2009
Date:6/19/2009

BEIJING, June 19 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products today announced selected unaudited preliminary financial results for the fourth fiscal quarter (''4Q FY2008'') and the full year of the fiscal year ended March 31, 2009 (''FY2008''). The Company's 2008 fiscal year ends on March 31, 2009.

    Selected Unaudited Preliminary Financial Results for 4Q FY2008
    -- Revenues from continuing operation increased by approximately 37% year-
       over-year to approximately RMB248 million (US$36 million).
    -- Non-GAAP adjusted income from continuing operation, as defined below,
       increased by approximately 43% year-over-year to approximately RMB116
       million (US$17 million).
    -- Non-GAAP adjusted diluted earnings from continuing operation per ADS*,
       as defined below, increased by approximately 44% year-over-year to
       approximately RMB4.4 (US$0.6).

    Selected Unaudited Preliminary Financial Results for FY2008
    -- Revenues from continuing operation increased by approximately 51% year-
       over-year to approximately RMB829 million (US$121 million).
    -- Non-GAAP adjusted income from continuing operation, as defined below,
       increased by approximately 79% year-over-year to approximately RMB416
       million (US$61 million).
    -- Non-GAAP adjusted diluted earnings from continuing operation per ADS*,
       as defined below, increased by approximately 80% year-over-year to
       approximately RMB15.8 (US$2.3).

    *One American Depositary Share (''ADS'') = 10 ordinary shares

The above selected numbers are preliminary in nature and are subject to change before the Company completes its financial reporting procedures. The Company expects to report its full unaudited financial results for 4Q FY2008 and FY2008 in late July 2009.

For the convenience of readers, certain RMB amounts have been translated into U.S. dollars at the rate of RMB6.8329 to US$1.00, the noon buying rate in New York City for cable transfers of RMB per U.S. dollar as set forth in the H.10 weekly statistical release of the Federal Reserve Board, as of Tuesday, March 31, 2009.

Non-GAAP Measure Disclosures

To supplement its consolidated financial statements presented in accordance with United States Generally Accepted Accounting Principles (''GAAP''), the Company uses non-GAAP measures of adjusted income from continuing operation and adjusted earnings from continuing operation per ADS, which are adjusted from results based on GAAP to exclude the impact of stock compensation expense, amortization of acquired intangible assets and acquired in-process research and development charge. Non-GAAP financial measures are used by the Company in their financial and operating decision-making because management believes they reflect the Company's ongoing business in a manner that allows meaningful period-to-period comparison. The Company's management believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating the Company's current operating performance and future prospects in the same manner as management does, if they so choose. The Company's management also believes the non-GAAP financial measures are useful for itself and investors because it makes more meaningful comparisons of the Company's current results of operations to those of prior periods.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com .

    For more information, please contact:

     Winnie Yam
     Tel:   +852-2511-9808
     Email: IR@chinameditech.com

'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin
2. NYSE Amex Accepts China Shenghuos Compliance Plan for Continued Listing
3. BMP Sunstone to be Featured on SIGs China Healthcare On Call Conference Call Series
4. China Sky One Medical, Inc. Obtains SFDA Approval for Diclofenac Sodium Eye Drops
5. China Nepstar Chain Drugstore Appoints Chief Operating Officer
6. China Sky One Medical, Inc. Welcomes Commercial Counselor from Belgium; Looks for Business Alliance with European Companies
7. China Nepstar Chain Drugstore Reports First Quarter 2009 Financial Results
8. China Nepstar Chain Drugstore Filed 2008 Annual Report on Form 20-F
9. China Kangtai Cactus Biotech Announces Goal to Expand and Enhance Shareholder Communication
10. Frost & Sullivan Looks at the Influence of Chinas New Health Reform on the Pharmaceutical Market
11. NSD Bio Group, LLC Selected By U.S. - China Economic & Security Review Commission for Analysis of Chinas Pharma Supply Chain on U.S. Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... (UCAOA) and College of Urgent Care Medicine will host industry leaders for the ... speakers will help those in the industry adapt to the issues currently affecting ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... of ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled ... wearable activity and sleep monitoring solutions for the global scientific community. The company’s ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Rob Lowe is ... now he has leant his presence to an educational purpose as the host of ... important one being cancer. In a recent episode, the series focuses on thyroid cancer. ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying to meet talent shortages ... outdated healthcare executive resume. , “If you’re a healthcare executive open to new opportunities ... if it’s as ready as you are for a new job search. I’ve heard ...
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs announced ... Lincoln, Neb. area this year. , The first new location will open at ... will open at 84th and Northern Lights Drive this fall. And the third location ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: